Human respiratory syncytial virus (RSV) is without doubt one of the main causes of childhood acute decrease respiratory tract an infection worldwide. Autophagy is an intracellular pathway concerned in nutrient recycling. Lately, autophagy has been reported to play a job in regulating host cytokine response to a number of viruses, together with vesicular stomatitis virus and human immunodeficiency virus. Earlier in vivo research utilizing mouse mannequin has proven that inhibition of autophagy reduces RSV-induced cytokine manufacturing. Nevertheless, the position of autophagy in modulating RSV-induced cytokine response in human cells has not been reported.
We investigated the position of autophagy in regulating the manufacturing of the cytokines C-X-C motif ligand 8 (CXCL8) and C-C motif ligand 5 (CCL5), in RSV-infected human bronchial epithelium BEAS-2B cells. Fluorescent microscopic evaluation confirmed that RSV an infection induced autophagosome formation in BEAS-2B cells. This autophagy inducing skill of RSV was additional confirmed by move cytometry. The consequences of pharmacological inhibition of autophagy by SAR405 or chloroquine on cell loss of life and cytokine launch have been quantified utilizing lactate dehydrogenase assay and enzyme-linked immunosorbent assay (ELISA), respectively. We discovered that SAR405 or chloroquine didn’t trigger cell loss of life.
Importantly, ELISA evaluation confirmed that pharmacological inhibition of autophagy by SAR405 or chloroquine didn’t have an effect on the productions of each CXCL5 and CXCL8. In distinction to the earlier research utilizing mouse mannequin, our knowledge counsel that pharmacological inhibition of autophagy is probably not an appropriate technique in controlling RSV-induced airway irritation. Colombia’s climatological selection, added to pathogen range, creates native niches for infectious ailments. In Bogotá, respiratory syncytial virus causes 30%-52% of the circumstances of respiratory infections.
In coastal or inter-Andean cities with increased temperature and longer dry seasons, frequency of this virus is 7%-13%. By 2017, elevated hospitalizations attributable to airway infections occurred in areas whose climate is otherwise influenced by “El Niño Southern Oscillation” than in Bogotá, though microbial range might need additionally been concerned.
Epidemiology of acute respiratory viral infections in youngsters in Vientiane, Lao Individuals’s Democratic Republic
Respiratory infections are one of the frequent causes for medical consultations in youngsters. In low useful resource settings similar to in Lao PDR, data gaps and the dearth of laboratory capability to help differential prognosis might contribute to antibiotic overuse. We studied the etiology, temporal developments and genetic range of viral respiratory infections in youngsters to offer proof for prevention and therapy pointers. From September 2014 to October 2015, throat swabs and nasopharyngeal aspirates from 445 youngsters underneath 10 years outdated with signs of acute respiratory an infection have been collected on the Kids Hospital in Vientiane.
Fast antigen exams have been carried out for influenza A and B and respiratory syncytial virus. Actual Time (RT-) PCRs have been carried out to detect 16 viruses. Influenza infections have been detected extra effectively with a better sensitivity utilizing PCR than with the fast antigen check. By (RT-)PCR screening, at the very least one pathogen could possibly be recognized for 71.7% of circumstances. Human rhinoviruses have been most regularly detected (29.9%), adopted by influenza A and B viruses mixed (15.9%). We establish and talk about seasonality of among the infections.
Altogether these knowledge present an in depth characterization of respiratory pathogens in Lao youngsters and we offer suggestions for vaccination and additional research. This text is protected by copyright. All rights reserved. The decrease infectivity of RSV(HBE) for HEp-2 cells is brought on by the diminished skill of LgG to work together with heparan sulfate proteoglycans (HSPG), the RSV receptor on HEp-2 cells. The invention of various infectivity corresponding with the bigger type of the RSV attachment protein when produced by HBE cultures highlights the significance of finding out a virus produced by its native host cell and the potential influence on quantifying virus infectivity on cell traces the place the virus entry mechanisms differ from their pure goal cell.
Prefusion F-Primarily based Polyanhydride Nanovaccine Induces Each Humoral and Cell-Mediated Immunity Leading to Lengthy-Lasting Safety in opposition to Respiratory Syncytial Virus
Respiratory syncytial virus (RSV) is a number one reason behind decrease respiratory tract an infection in each younger youngsters and in older adults. Regardless of the morbidity, mortality, and excessive financial burden brought on by RSV worldwide, no licensed vaccine is at present out there. We’ve developed a novel RSV vaccine composed of a prefusion-stabilized variant of the fusion (F) protein (DS-Cav1) and a CpG oligodeoxynucleotide adjuvant encapsulated inside polyanhydride nanoparticles, termed RSVNanoVax. A primary-boost intranasal administration of RSVNanoVax in BALB/c mice considerably alleviated weight reduction and pulmonary dysfunction in response to an RSV problem, with safety maintained as much as at the very least 6 mo postvaccination.
As well as, vaccinated mice exhibited fast viral clearance within the lungs as early as 2 d after RSV an infection in each inbred and outbred populations. Vaccination induced tissue-resident reminiscence CD4 and CD8 T cells within the lungs, in addition to RSV F-directed neutralizing Abs. Primarily based on the strong immune response elicited and the excessive stage of sturdy safety noticed, our prefusion RSV F nanovaccine is a promising new RSV vaccine candidate.
 Antibody) Respiratory Syncytial Virus Fusion Protein Antibody (RSV-F) Antibody |
|
abx415700-01mg |
Abbexa |
0.1 mg |
EUR 777.6 |
|
|
Respiratory Syncytial Virus Fusion Protein Antibody (RSV-F) Antibody |
|
abx415700-200l |
Abbexa |
200 µl |
EUR 625 |
Respiratory Syncytial Virus Fusion Protein Antibody (RSV-F) Antibody |
|
abx414442-01mg |
Abbexa |
0.1 mg |
EUR 526.8 |
|
|
Respiratory Syncytial Virus Fusion Protein Antibody (RSV-F) Antibody |
|
abx414442-200l |
Abbexa |
200 µl |
EUR 650 |
 OASA04274-1MG - RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN Antibody |
|
OASA04274-1MG |
Aviva Systems Biology |
1mg |
EUR 699 |
|
|
 OASA04272-200UG - RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN Antibody |
|
OASA04272-200UG |
Aviva Systems Biology |
0.2mg |
EUR 459 |
|
|
 OASA04273-100UG - RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN Antibody |
|
OASA04273-100UG |
Aviva Systems Biology |
0.1mg |
EUR 309 |
|
|
 OASA04275-100UG - RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN Antibody |
|
OASA04275-100UG |
Aviva Systems Biology |
0.1mg |
EUR 649 |
|
|
) Respiratory Syncytial Virus, Fusion Protein (RSV) |
|
MBS624043-01mg |
MyBiosource |
0.1mg |
EUR 795 |
Respiratory Syncytial Virus, Fusion Protein (RSV) |
|
MBS624043-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3435 |
Respiratory Syncytial Virus, Fusion Protein (RSV) |
|
MBS633332-1mg |
MyBiosource |
1mg |
EUR 1065 |
Respiratory Syncytial Virus, Fusion Protein (RSV) |
|
MBS633332-5x1mg |
MyBiosource |
5x1mg |
EUR 4645 |
Respiratory Syncytial Virus, Fusion Protein (RSV) |
|
MBS633361-02mg |
MyBiosource |
0.2mg |
EUR 635 |
Respiratory Syncytial Virus, Fusion Protein (RSV) |
|
MBS633361-5x02mg |
MyBiosource |
5x0.2mg |
EUR 2700 |
Respiratory Syncytial Virus, Fusion Protein (RSV) |
|
MBS632043-02mg |
MyBiosource |
0.2mg |
EUR 715 |
Respiratory Syncytial Virus, Fusion Protein (RSV) |
|
MBS632043-5x02mg |
MyBiosource |
5x0.2mg |
EUR 3075 |
Respiratory Syncytial Virus, Fusion Protein (RSV) |
|
MBS632929-1mL |
MyBiosource |
1mL |
EUR 555 |
Respiratory Syncytial Virus, Fusion Protein (RSV) |
|
MBS632929-5x1mL |
MyBiosource |
5x1mL |
EUR 2355 |
Respiratory Syncytial Virus, Fusion Protein (RSV) |
|
MBS633119-1mg |
MyBiosource |
1mg |
EUR 1180 |
Respiratory Syncytial Virus, Fusion Protein (RSV) |
|
MBS633119-5x1mg |
MyBiosource |
5x1mg |
EUR 5150 |
Respiratory Syncytial Virus, Fusion Protein (RSV) |
|
MBS632813-01mg |
MyBiosource |
0.1mg |
EUR 885 |
Respiratory Syncytial Virus, Fusion Protein (RSV) |
|
MBS632813-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3830 |
Respiratory Syncytial Virus, Fusion Protein (RSV) |
|
MBS609939-1mg |
MyBiosource |
1mg |
EUR 690 |
Respiratory Syncytial Virus, Fusion Protein (RSV) |
|
MBS609939-5x1mg |
MyBiosource |
5x1mg |
EUR 2950 |
Respiratory Syncytial Virus, Fusion Protein (RSV) |
|
MBS609550-01mL |
MyBiosource |
0.1mL |
EUR 695 |
Respiratory Syncytial Virus, Fusion Protein (RSV) |
|
MBS609550-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2975 |
 MOUSE ANTI RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN |
|
MBS212943-01mg |
MyBiosource |
0.1mg |
EUR 515 |
MOUSE ANTI RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN |
|
MBS212943-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2145 |
MOUSE ANTI RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN |
|
MBS213317-01mg |
MyBiosource |
0.1mg |
EUR 745 |
MOUSE ANTI RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN |
|
MBS213317-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3175 |
MOUSE ANTI RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN |
|
MBS213044-1mg |
MyBiosource |
1mg |
EUR 805 |
MOUSE ANTI RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN |
|
MBS213044-5x1mg |
MyBiosource |
5x1mg |
EUR 3440 |
MOUSE ANTI RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN |
|
MBS211901-02mg |
MyBiosource |
0.2mg |
EUR 515 |
MOUSE ANTI RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN |
|
MBS211901-5x02mg |
MyBiosource |
5x0.2mg |
EUR 2145 |
 Mouse anti Respiratory Syncytial Virus Fusion Protein Monoclonal Antibody |
|
DCAB-TJ113 |
Creative Diagnostics |
0.5 mg; 1 mg |
Ask for price |
Mouse anti Respiratory Syncytial Virus Fusion Protein Monoclonal Antibody |
|
DCAB-TJ113-05mg |
Creative Diagnostics |
0.5 mg |
EUR 1162.8 |
Mouse anti Respiratory Syncytial Virus Fusion Protein Monoclonal Antibody |
|
DCAB-TJ113-1mg |
Creative Diagnostics |
1 mg |
EUR 1762.8 |
Mouse anti Respiratory Syncytial Virus Fusion Protein Monoclonal Antibody |
|
DCAB-TJ114 |
Creative Diagnostics |
0.5 mg; 1 mg |
Ask for price |
|
|
|
Description: Mouse |
Mouse anti Respiratory Syncytial Virus Fusion Protein Monoclonal Antibody |
|
DCAB-TJ114-05mg |
Creative Diagnostics |
0.5 mg |
EUR 1162.8 |
Mouse anti Respiratory Syncytial Virus Fusion Protein Monoclonal Antibody |
|
DCAB-TJ114-1mg |
Creative Diagnostics |
1 mg |
EUR 1762.8 |
 (AP)) Respiratory Syncytial Virus, Fusion Protein (RSV) (AP) |
|
MBS6248270-01mL |
MyBiosource |
0.1(mL |
EUR 1275 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (AP) |
|
MBS6248270-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5585 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (AP) |
|
MBS6248272-01mL |
MyBiosource |
0.1(mL |
EUR 995 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (AP) |
|
MBS6248272-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4325 |
 (PE)) Respiratory Syncytial Virus, Fusion Protein (RSV) (PE) |
|
MBS6252145-01mL |
MyBiosource |
0.1(mL |
EUR 1275 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (PE) |
|
MBS6252145-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5585 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (PE) |
|
MBS6252147-01mL |
MyBiosource |
0.1(mL |
EUR 995 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (PE) |
|
MBS6252147-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4325 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (AP) |
|
MBS6260205-01mL |
MyBiosource |
0.1mL |
EUR 870 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (AP) |
|
MBS6260205-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3760 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (PE) |
|
MBS6262756-01mL |
MyBiosource |
0.1mL |
EUR 870 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (PE) |
|
MBS6262756-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3760 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (PE) |
|
MBS6129575-01mL |
MyBiosource |
0.1(mL |
EUR 795 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (PE) |
|
MBS6129575-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3435 |
) Respiratory Syncytial Virus, Fusion Protein 1c (RSV) |
|
MBS603612-01mg |
MyBiosource |
0.1mg |
EUR 690 |
Respiratory Syncytial Virus, Fusion Protein 1c (RSV) |
|
MBS603612-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2965 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (AP) |
|
MBS6126479-01mL |
MyBiosource |
0.1(mL |
EUR 795 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (AP) |
|
MBS6126479-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3435 |
 (HRP)) Respiratory Syncytial Virus, Fusion Protein (RSV) (HRP) |
|
MBS6251204-01mL |
MyBiosource |
0.1(mL |
EUR 1275 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (HRP) |
|
MBS6251204-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5585 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (HRP) |
|
MBS6251206-01mL |
MyBiosource |
0.1(mL |
EUR 995 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (HRP) |
|
MBS6251206-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4325 |
 (APC)) Respiratory Syncytial Virus, Fusion Protein (RSV) (APC) |
|
MBS6260716-01mL |
MyBiosource |
0.1mL |
EUR 870 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (APC) |
|
MBS6260716-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3760 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (HRP) |
|
MBS6262246-01mL |
MyBiosource |
0.1mL |
EUR 870 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (HRP) |
|
MBS6262246-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3760 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (APC) |
|
MBS6127099-01mL |
MyBiosource |
0.1(mL |
EUR 795 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (APC) |
|
MBS6127099-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3435 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (HRP) |
|
MBS6128955-01mL |
MyBiosource |
0.1(mL |
EUR 795 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (HRP) |
|
MBS6128955-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3435 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (APC) |
|
MBS6269122-01mL |
MyBiosource |
0.1mL |
EUR 1275 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (APC) |
|
MBS6269122-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5585 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (APC) |
|
MBS6269124-01mL |
MyBiosource |
0.1mL |
EUR 995 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (APC) |
|
MBS6269124-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4325 |
 (FITC)) Respiratory Syncytial Virus, Fusion Protein (RSV) (FITC) |
|
MBS6250185-01mL |
MyBiosource |
0.1(mL |
EUR 1275 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (FITC) |
|
MBS6250185-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5585 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (FITC) |
|
MBS6250187-01mL |
MyBiosource |
0.1(mL |
EUR 995 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (FITC) |
|
MBS6250187-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4325 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (FITC) |
|
MBS6261735-01mL |
MyBiosource |
0.1mL |
EUR 870 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (FITC) |
|
MBS6261735-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3760 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (FITC) |
|
MBS6128334-01mL |
MyBiosource |
0.1(mL |
EUR 795 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (FITC) |
|
MBS6128334-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3435 |
 (Biotin)) Respiratory Syncytial Virus, Fusion Protein (RSV) (Biotin) |
|
MBS6249278-01mL |
MyBiosource |
0.1(mL |
EUR 1275 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (Biotin) |
|
MBS6249278-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5585 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (Biotin) |
|
MBS6249280-01mL |
MyBiosource |
0.1(mL |
EUR 995 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (Biotin) |
|
MBS6249280-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4325 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (Biotin) |
|
MBS6261227-01mL |
MyBiosource |
0.1mL |
EUR 870 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (Biotin) |
|
MBS6261227-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3760 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (Biotin) |
|
MBS6127719-01mL |
MyBiosource |
0.1(mL |
EUR 795 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (Biotin) |
|
MBS6127719-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3435 |
 (AP)) Respiratory Syncytial Virus, Fusion Protein 1c (RSV) (AP) |
|
MBS6241788-01mL |
MyBiosource |
0.1(mL |
EUR 980 |
Respiratory Syncytial Virus, Fusion Protein 1c (RSV) (AP) |
|
MBS6241788-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4265 |
 (PE)) Respiratory Syncytial Virus, Fusion Protein 1c (RSV) (PE) |
|
MBS6244452-01mL |
MyBiosource |
0.1(mL |
EUR 980 |
Respiratory Syncytial Virus, Fusion Protein 1c (RSV) (PE) |
|
MBS6244452-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4265 |
) Respiratory Syncytial Virus, Fusion Protein A,B (RSV) |
|
MBS604467-1mL |
MyBiosource |
1mL |
EUR 555 |
Respiratory Syncytial Virus, Fusion Protein A,B (RSV) |
|
MBS604467-5x1mL |
MyBiosource |
5x1mL |
EUR 2355 |
) Respiratory Syncytial Virus, A,B, Fusion Protein (RSV) |
|
MBS608318-1mL |
MyBiosource |
1mL |
EUR 580 |
Respiratory Syncytial Virus, A,B, Fusion Protein (RSV) |
|
MBS608318-5x1mL |
MyBiosource |
5x1mL |
EUR 2470 |
Respiratory Syncytial Virus, Fusion Protein A,B (RSV) |
|
MBS607589-01mg |
MyBiosource |
0.1mg |
EUR 710 |
Respiratory Syncytial Virus, Fusion Protein A,B (RSV) |
|
MBS607589-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3050 |
Respiratory Syncytial Virus, Fusion Protein A,B (RSV) |
|
MBS608900-1mL |
MyBiosource |
1mL |
EUR 580 |
Respiratory Syncytial Virus, Fusion Protein A,B (RSV) |
|
MBS608900-5x1mL |
MyBiosource |
5x1mL |
EUR 2470 |
 Fusion, Antibody) Respiratory Syncytial Virus (RSV) Fusion, Antibody |
|
GWB-C230D4 |
GenWay Biotech |
0.1 mg |
Ask for price |
 (APC)) Respiratory Syncytial Virus, Fusion Protein 1c (RSV) (APC) |
|
MBS6242321-01mL |
MyBiosource |
0.1(mL |
EUR 980 |
Respiratory Syncytial Virus, Fusion Protein 1c (RSV) (APC) |
|
MBS6242321-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4265 |
 (HRP)) Respiratory Syncytial Virus, Fusion Protein 1c (RSV) (HRP) |
|
MBS6243919-01mL |
MyBiosource |
0.1(mL |
EUR 980 |
Respiratory Syncytial Virus, Fusion Protein 1c (RSV) (HRP) |
|
MBS6243919-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4265 |
 (FITC)) Respiratory Syncytial Virus, Fusion Protein 1c (RSV) (FITC) |
|
MBS6243386-01mL |
MyBiosource |
0.1(mL |
EUR 980 |
Respiratory Syncytial Virus, Fusion Protein 1c (RSV) (FITC) |
|
MBS6243386-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4265 |
 (Biotin)) Respiratory Syncytial Virus, Fusion Protein 1c (RSV) (Biotin) |
|
MBS6242853-01mL |
MyBiosource |
0.1(mL |
EUR 980 |
Respiratory Syncytial Virus, Fusion Protein 1c (RSV) (Biotin) |
|
MBS6242853-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4265 |
 (AP)) Respiratory Syncytial Virus, Fusion Protein A,B (RSV) (AP) |
|
MBS6248273-01mL |
MyBiosource |
0.1(mL |
EUR 965 |
Respiratory Syncytial Virus, Fusion Protein A,B (RSV) (AP) |
|
MBS6248273-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4185 |
 (PE)) Respiratory Syncytial Virus, Fusion Protein A,B (RSV) (PE) |
|
MBS6252148-01mL |
MyBiosource |
0.1(mL |
EUR 965 |
Respiratory Syncytial Virus, Fusion Protein A,B (RSV) (PE) |
|
MBS6252148-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4185 |
 (MaxLight 550)) Respiratory Syncytial Virus, Fusion Protein (RSV) (MaxLight 550) |
|
MBS6255258-01mL |
MyBiosource |
0.1(mL |
EUR 1275 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (MaxLight 550) |
|
MBS6255258-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5585 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (MaxLight 550) |
|
MBS6255260-01mL |
MyBiosource |
0.1(mL |
EUR 995 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (MaxLight 550) |
|
MBS6255260-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4325 |
 (MaxLight 750)) Respiratory Syncytial Virus, Fusion Protein (RSV) (MaxLight 750) |
|
MBS6257337-01mL |
MyBiosource |
0.1mL |
EUR 1275 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (MaxLight 750) |
|
MBS6257337-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5585 |
Respiratory Syncytial Virus, Fusion Protein (RSV) (MaxLight 750) |
|
MBS6257339-01mL |
MyBiosource |
0.1mL |
EUR 995 |
Respiratory syncytial virus (RSV) infects the higher and decrease respiratory tracts and might trigger decrease respiratory tract infections in youngsters and elders. RSV has historically been remoted, grown, studied and quantified in immortalized cell traces, most regularly HEp-2 cells. Nevertheless, in vivo RSV an infection is modeled extra precisely in main effectively differentiated human bronchial epithelial (HBE) cultures the place RSV targets the ciliated cells and the place the putative RSV receptor differs from the receptor on HEp-2 cells. The RSV attachment (G) glycoprotein in virions produced by HEp-2 cells is a extremely glycosylated 95 kDa protein with a 32 kDa peptide core.